Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL...
Regarding dropouts, are we forgetting about the requirements some sites placed on trial participants as the result of COVID?
Some sites required all patients to be vaccinated! I believe most of the dropouts are related to this requirement alone, as most parents wouldn't want to subject their precious daughters to a vaccine that could cause further health problems (e.g. myocarditis) or worse.
So, frrol, what does clinicaltrials.gov say about seizure monitoring? Or is it just an RWE thing? 🤡
Do you THINK to check clinicaltrials.gov before you type your nonsense? 🤡
12.9 point drop with blarcamesine
An astute investor would take the time to review clinicaltrials.gov for Rett Excellence, and find that seizure frequency is part of the trial design.
He makes valid points. There is certainly an "improvement" bias in evaluating these young girls, which distorts results.
Comparing blarcamesine efficacy vs. Daybue is indicative of blarcamesine's superiority, with no adverse side effects.
From today's PR...
In addition to the Rett efficacy + safety results and biometrics, the FDA will most certainly value the RWE data...
Paid FUDsters, including AF, spin negative narratives even when the results are exceedingly positive to provide a smokescreen for the collusive HF cabal behind the scenes with their manipulation schemes.
The results today, showing 3X the efficacy of Daybue, combined with the impending genetic data and RWE of real patients improving (e.g. reduced seizures) and safety profile, is clear evidence of a successful drug for Rett. I fully expect that an NDA will be submitted after review with the FDA.
AD is already on the approval path with the EMA.
All indications are pointing upward.
I added 50% additional shares the last time we were manipulated down to $5. I doubt we get back to there, when there's positive news in the waiting.
More like a wise-a$$ FUDster.
Wow... all the old-time FUDsters showing up today. LOL
We've only been presented the TLR... which actually showed 3x the efficacy of Daybue.
FUDsters get to wait for the rest of the data, genetic and seizure results, before having to eat crow.
Regardless of the trial results, you're still FUDsters.
You're trying to call the game when there's still another quarter yet to play. LOL
Not all of the cards have been played yet. Pick your metaphor, FUDster.
I live in reality... but I have my suspicions about you.
There's nothing that Fraudstein says is true. He's a paid spinster and liar.
Shareholders have nothing to worry about... except when to buy more shares!
Certainly before the additional Rett data are released that reveal genetic improvements and seizure reduction. Seizure reduction, alone, along with the safety data warrants fast track approval.
And certainly before the peer-reviewed journal article is published.
We haven't seen the genetic and biodata, yet... including seizure reduction. Not a long row at all!
It'll be much more impressive once we see the biodata... and the seizure reduction.
Don't play or fall for the spin jobs.... just go with the facts. Blarcamesine is effective and the evaluation isn't over.
There's that spin job we were waiting for...
100%? LOL 🤡
Rolling submissions are rarely PR'd due to the nature of the submission.
How do you PR a rolling submission when it's not completely submitted?
It's the acceptance that is relevant and material in a rolling submission, as it signifies completeness.
Submitting an NDA is not a material event in itself; however, the acceptance might me.
The slide speaks for itself. You, on the other hand, post mountains of misinformation and FUD. 👺
For the FUDsters it's a job.
It is NOT misinformation; it's a corporate slide.
You're the one providing misinformation in all of your FUD posts. 👺
NEWBIES BEWARE!
For some, five is not nearly enough.
Applying FUDster 👺 stamps as appropriate...
Couldn't resist this manipulated price to add 5k more shares before news.
I didn't see him blame anyone. The process is the process and it takes everyone doing their part.
I saw no "promises" made, just an expectation... and therefore I believe it's very close, perhaps a week or two. It seems the "market" is expecting the same.
LOL. You call it lying? That's funny.
So when you can't deliver an assignment to your boss on time, that you said you could make, but someone didn't deliver what you needed, you would be accused of lying. Got it.
So, you would've been happier if he offered no anticipated timeframe when asked when we should expect to see results?
A response of, "Whenever it's ready" would've been sufficient for you?
To support the handlers' plans, I'm sure you'll be ready with your contribution in the form of another lying pre-written hit piece to crap on the board when the very positive Excellence TLR is revealed. 👺
That false comment right there just proved it. 👺
Not even great news and data can prevent your lies and distortions. 👺
Would be nice to shut the 👺s up!
It's absolutely FUD when the evidence has been presented, but FUDsters continue to dismiss it.
Read carefully...